Kalehua Capital Management LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, Kalehua Capital Management LLC held in its portfolio 19 assets valued at $101,099,761 (i.e. $101.10M).

The most valuable assets in the portfolio included: Alpha Architect 1-3 Month Box Etf ($26.56M), X4 Pharmaceuticals Inc ($14.89M), and Sionna Therapeutics Inc ($8.11M).

The chart below shows the top 10 valuable assets, and the table below shows the top 19 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Kalehua Capital Management LLC Portfolio

Alpha Architect 1-3 Month Box Etf

X4 Pharmaceuticals Inc

Sionna Therapeutics Inc

Relay Therapeutics Inc

Compass Pathways Plc

Pharvaris NV

Septerna Inc

Oruka Therapeutics Inc

Inhibikase Therapeutics Inc

Allogene Therapeutics Inc

Kalehua Capital Management LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
Alpha Architect 1-3 Month Box Etf	230787	26563584	ALPHA ARCH 1-3
X4 Pharmaceuticals Inc	3722840	14891360	COM NEW
Sionna Therapeutics Inc	197072	8107542	COM
Relay Therapeutics Inc	901457	7626326	COM
Compass Pathways Plc	819692	5655875	SPONSORED ADS
Pharvaris NV	198772	5515923	COM
Septerna Inc	194544	5423887	COM
Oruka Therapeutics Inc	118524	3592462	COM
Inhibikase Therapeutics Inc	1750000	3587500	COM NEW
Allogene Therapeutics Inc	2546129	3488197	COM
LeonaBio Inc	393701	2980317	COM
MoonLake Immunotherapeutics	175734	2316174	CLASS A ORD
Oric Pharmaceuticals Inc	267059	2184543	COM
Verrica Pharmaceuticals Inc	235779	1959323	COM SHS
Tyra Biosciences Inc	74465	1957685	COM
Surrozen Inc	385178	1886241	COM NEW
Tenaya Therapeutics Inc	2000000	1423000	COM
Kalaris Therapeutics Inc	139901	1180764	COM
Diamedica Therapeutics Inc	95359	759058	COM NEW